Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News OKEA to acquire Repsol Norge’s 40% operated interest in Vette oil discovery and PL 972 Find out how OKEA’s acquisition of Repsol’s Vette oil stake could unlock low-cost development potential across Norway’s sub-100 mmboe offshore fields. byoilandgasnews365 reporterDecember 20, 2020